Impact of Atogepant on Migraine-Specific QoL Among Individuals With Episodic Migraine and Preventive Treatment Failure

被引：0
|
作者：
Tassorelli, C. [1 ,2 ]
Gandhi, P. [3 ]
Sacco, S. [4 ]
Pozo-Rosich, P. [5 ,6 ]
Lanteri-Minet, M. [7 ,8 ,9 ]
Nezadal, T. [10 ]
Trugman, J.
Luo, L. [3 ]
Stokes, J. [3 ]
Nagy, K. [11 ]
机构：
[1] C Mondino Fdn, Headache Sci Ctr, Pavia, Italy
[2] Univ Pavia, Pavia, Italy
[3] AbbVie, Madison, NJ USA
[4] Carolinas Headache Clin, Matthews, NC USA
[5] Vall DHebron Univ Hosp, Barcelona, Spain
[6] Univ Autonoma Barcelona, Barcelona, Spain
[7] CHU Nice, Pain Dept, Nice, France
[8] CHU Nice, FHU InovPain, Nice, France
[9] Cote Azur Univ, Nice, France
[10] Charles Univ Prague, Mil Univ Hosp, Sch Med 1, Dept Neurol, Prague, Czech Republic
[11] AbbVie, Budapest, Hungary
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-139
引用
收藏
页码：214 / 215
页数：2
相关论文
共 50 条
  • [1] Effect of Atogepant on Headache Impact Test-6 Among Individuals With Episodic Migraine and Preventive Treatment Failure
    Tassorelli, C.
    Gandhi, P.
    Sacco, S.
    Pozo-Rosich, P.
    Lanteri-Minet, M.
    Nezadal, T.
    Trugman, J.
    Luo, L.
    Stokes, J.
    Nagy, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 215 - 216
  • [2] Atogepant for the Preventive Treatment of Migraine Among Participants With Episodic Migraine With Prior Treatment Failure: Results From the ELEVATE Trial
    Pozo-Rosich, P.
    Nagy, K.
    Tassorelli, C.
    Lanteri-Minet, M.
    Sacco, S.
    Nezadal, T.
    Finnegan, M.
    Guo, H.
    Ferreira, De Abreu R.
    Trugman, J.
    HEADACHE, 2023, 63 : 117 - 117
  • [3] Atogepant for the Preventive Treatment of Migraine Among Participants With Episodic Migraine With Prior Treatment Failure: Results From the ELEVATE Trial
    Pozo-Rosich, Patricia
    Nagy, Krisztian
    Tassorelli, Cristina
    Lanteri-Minet, Michel
    Sacco, Sara
    Nezadal, Tomas
    Finnegan, Michelle
    Guo, Hua
    Ferreira, Rosa De Abreu
    Trugman, Joel M.
    CEPHALALGIA, 2023, 43 (1supp) : 47 - 49
  • [4] Atogepant for the Preventive Treatment of Migraine
    Ailani, Jessica
    Lipton, Richard B.
    Goadsby, Peter J.
    Guo, Hua
    Miceli, Rosa
    Severt, Lawrence
    Finnegan, Michelle
    Trugman, Joel M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 695 - 706
  • [5] The Impact of Fremanezumab on Migraine-Specific Health-Related Quality of Life in Episodic Migraine
    Lipton, R. B.
    Gandhi, S. K.
    Fitzgerald, T.
    Yeung, P. P.
    Cohen, J. M.
    Ma, Y.
    Aycardi, E.
    HEADACHE, 2018, 58 : 129 - 129
  • [6] The Impact of Fremanezumab on Migraine-Specific Health-Related Quality of Life in Episodic Migraine
    Lipton, Richard B.
    Gandhi, Sanjay K.
    Fitzgerald, Timothy
    Yeung, Paul P.
    Cohen, Joshua M.
    Ma, Yuju
    Aycardi, Ernesto
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [7] The Impact of Fremanezumab on Migraine-Specific Health-Related Quality of Life in Episodic Migraine
    Lipton, Richard B.
    Gandhi, Sanjay K.
    Fitzgerald, Timothy
    Yeung, Paul P.
    Cohen, Joshua M.
    Ma, Yuju
    Aycardi, Ernesto
    NEUROLOGY, 2018, 90
  • [8] Atogepant Improved Patient-Reported Migraine-Specific Quality of Life in a 12-Week Phase 3 (ADVANCE) Trial for Preventive Treatment of Migraine
    Lipton, R. B.
    Pozo-Rosich, P.
    Blumenfeld, A. M.
    Li, Y.
    Severt, L.
    Stokes, J.
    Gandhi, P.
    Dodick, D. W.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 106 - 107
  • [9] Atogepant improved patient-reported migraine-specific quality of life in a 12-week phase 3 (ADVANCE) trial for preventive treatment of migraine
    Lipton, R. B.
    Pozo-Rosich, P.
    Blumenfeld, A. M.
    Li, Y.
    Severt, L.
    Stokes, J.
    Gandhi, P.
    Dodick, D. W.
    HEADACHE, 2021, 61 : 43 - 44
  • [10] Atogepant Improved Patient-Reported Migraine-Specific Quality of Life in a 12-Week Phase 3 (ADVANCE) Trial for Preventive Treatment of Migraine
    Dodick, David W.
    Pozo-Rosich, Patricia
    Blumenfeld, Andrew M.
    Li, Ye
    Severt, Lawrence
    Stokes, Jonathan
    Gandhi, Pranav
    Lipton, Richard B.
    NEUROLOGY, 2021, 96 (15)
12345